News

Piramal Pharma Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation  

Piramal Pharma Limited has informed the Exchange regarding appointment of Ms. Pratibha Mishra as Company Secretary & Compliance Officer of the Company w.e.f. February 21, 2026. |SUBJECT: Appointment  

Piramal Pharma Limited has informed the Exchange regarding resignation of Ms. Tanya Sanish as Company Secretary & Compliance Officer of the Company w.e.f. February 20, 2026. |SUBJECT: Resignation  

Chemfab Alkalis Limited has informed the Exchange regarding ‘Investor presentation forthe quarter ended December 31, 2025’. |SUBJECT: Updates  

A bipartisan bill introduced in the House in mid-January joins a few other proposals that aim to make it as easy to cancel a subscription as it is to sign up.  

Forecasters don’t believe the next Fed chair installed by President Donald Trump will drive down overnight rates toward the low levels demanded by the president.  

The fourth-quarter earnings season will give the megacaps an opportunity to lay out their 2026 spending visions and, in some cases, defend those plans.  

Tesla’s brand value declined while BYD’s surged last year, according to research by Brand Finance  

The trade deal is being widely seen as a strategic hedge against volatile U.S. trade policies.  

Minnesota state officials have pressed for ICE and other immigration authorities to cease aggressive actions in Minneapolis and elsewhere in the state.